Mendelian randomization, lipids, and coronary artery disease: trade-offs between study designs and assumptions
American Journal of Epidemiology · 2025
DOI: 10.1093/aje/kwaf190 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Joy Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Population Health and Data Sciences, Massachusetts Veterans Epidemiology Research and Information Collaborative (MAVERIC), VA Boston Heal…. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Coronary Artery Disease, Cholesterol, LDL, Cholesterol, HDL. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: CSP VA, Million Veteran Program, Cooperative Studies Program.
Abstract (Originalsprache)
Mendelian randomization (MR) studies have been described as naturally occurring randomized trials. However, MR studies often deviate from appropriate trial design principles, and many use two-sample designs with strong assumptions not required in randomized trials. Using data from the Million Veteran Program, we empirically evaluated the impact of study design choices and two-sample approaches in an MR study of lipids and coronary artery disease. We designed an MR study of participants of European descent with no history of coronary artery disease and no contraindications to low-density lipoprotein cholesterol (LDL-C)–related therapies to estimate 10-year odds ratios of coronary artery disease per 39 mg/dL increase in LDL-C or 15.8 mg/dL increase in high-density lipoprotein cholesterol (HDL-C). We then sequentially modified the design to reflect common decisions made in MR studies. For LDL-C, one-sample estimates ranged from 1.50 (95% CI, 1.34 − 1.68) to 2.23 (95% CI, 1.93 − 2.59) and two-sample estimates from 1.13 (95% CI, 1.01 − 1.26) to 1.30 (95% CI, 1.15 − 1.46). For HDL-C, estimates ranged from 0.76 (95% CI, 0.68 − 0.86) to 0.93 (95% CI, 0.65 − 1.34) across one- versus two-sample analyses. Estimates were most sensitive to the inclusion of prevalent outcomes. These results indicate the magnitude of MR estimates can vary with study design. We recommend future MR studies assess the sensitivity of estimates to different design decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Population Health and Data Sciences, Massachusetts Veterans Epidemiology Research and Information Collaborative (MAVERIC), VA Boston Healthcare System, Boston, MA, United States.
- CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
- Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, United States.
- Department of Medicine, Veteran Affairs Atlanta Healthcare System, Decatur, GA, United States.
- Division of Cardiology, Emory University School of Medicine, Atlanta, GA, United States.
ORCID-Profile: Joy Shi, Hanna Gerlovin, Kelly Cho, Miguel A Hernán
Förderung
- CSP VA
- Million Veteran Program
- Cooperative Studies Program
Zitieren
APA
Shi, J., Swanson, S. A., Diemer, E. W., Gerlovin, H., Posner, D. C., Wilson, P. W. F., Gaziano, J. M., Cho, K., Hernán, M. A., & VA Million Veteran Program (2025). Mendelian randomization, lipids, and coronary artery disease: trade-offs between study designs and assumptions. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwaf190
Vancouver
Shi J, Swanson SA, Diemer EW, Gerlovin H, Posner DC, Wilson PWF, et al. Mendelian randomization, lipids, and coronary artery disease: trade-offs between study designs and assumptions. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwaf190
BibTeX
@article{Shi2025,
author = {Shi, Joy and Swanson, Sonja A and Diemer, Elizabeth W and Gerlovin, Hanna and Posner, Daniel C and Wilson, Peter W F and Gaziano, J Michael and Cho, Kelly and Hernán, Miguel A and VA Million Veteran Program, VA Million Veteran Program},
title = {Mendelian randomization, lipids, and coronary artery disease: trade-offs between study designs and assumptions},
journal = {American Journal of Epidemiology},
year = {2025},
doi = {10.1093/aje/kwaf190}
}
EUVIMED